Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV

Jeffrey S. Barrett; Sergei Spitsin; Ganesh Moorthy; Kyle Barrett; Kate Baker; Andrew Lackner; Florin Tulic; Angela Winters; Dwight L. Evans; Steven D. Douglas

doi:10.1186/s12967-016-0904-y

Back

Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV

Journal article

Open access

Peer reviewed

Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV

Jeffrey S. Barrett, Sergei Spitsin, Ganesh Moorthy, Kyle Barrett, Kate Baker, Andrew Lackner, Florin Tulic, Angela Winters, Dwight L. Evans and Steven D. Douglas

Journal of translational medicine, v 14(1), pp 148-148

26 May 2016

DOI: https://doi.org/10.1186/s12967-016-0904-y

PMID: 27230663

Featured in Collection : UN Sustainable Development Goals @ Drexel

Files and links (1)

url

https://doi.org/10.1186/s12967-016-0904-yView

Published, Version of Record (VoR)CC BY V4.0, Open

Abstract

Aprepitant

HIV

HIV associated neurocognitive disorder

Inflammation

Neurokinin 1 receptor

SIV

Substance P

Metrics

3 Record Views

18 citations in Web of Science

18 citations in Scopus

Details

Title: Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV
Creators: Jeffrey S. Barrett - Children's Hospital of Philadelphia
Sergei Spitsin - Children's Hospital of Philadelphia
Ganesh Moorthy - Children's Hospital of Philadelphia
Kyle Barrett - Children's Hospital of Philadelphia
Kate Baker - Tulane University
Andrew Lackner - Tulane University
Florin Tulic - University of Pennsylvania
Angela Winters - Children's Hospital of Philadelphia
Dwight L. Evans - University of Pennsylvania
Steven D. Douglas - University of Pennsylvania
Publication Details: Journal of translational medicine, v 14(1), pp 148-148
Publisher: BioMed Central
Grant note: R21 AI 108296 / ; U01 MH-090325; P01 MH-076388; R01-MH082670; P01 MH-105303; R01 MH-049981; P30 MH097488 / ;
Resource Type: Journal article
Language: English
Academic Unit: Chemical and Biological Engineering
Web of Science ID: WOS:000377182600001
Scopus ID: 2-s2.0-84969983991
Other Identifier: 991019168044904721

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: Industry collaboration; Domestic collaboration
Web of Science research areas: Medicine, Research & Experimental

Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV

Files and links (1)

Abstract

Metrics

Details

UN Sustainable Development Goals (SDGs)

InCites Highlights

Drexel University Social media